English

ARIAD PHARMACEUTICALS INC

EDGAR

ARIA Quarterly report amendment (10-Q/A) · filed 2017-02-13

160 filing records in this dataset, filed from 1996-05-08 to 2017-02-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

46 million USD

2016 Q3 · USD

Exact inputs and evidence

Revenue: 46016000 USD Source

Operating margin

-54.31%

2016 Q3 · %

Exact inputs and evidence

Operating Income: -24990000 USD Source
Revenue: 46016000 USD Source

Operating cash flow

-23.7 million USD

2016 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -121436000 USD Source
Operating Cash Flow: -97747000 USD Source

Cash and cash equivalents: 305 million USD 2016-09-30 Source
Exact value

305038000 USD
Long-term debt including current maturities: 553 million USD 2016-09-30 Source
Exact value

552919000 USD
Shares outstanding: 194 million shares 2016-09-30 Source
Exact value

194091892 shares

Reported share-count change

2.59% · 4.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

189189890 shares · 2015-09-30· Source
194091892 shares · 2016-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

186 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Revenue: 118804000 USD · 2015-01-01 – 2015-12-31 Source
Revenue: 82300000 USD · 2015-01-01 – 2015-09-30 Source
Revenue: 35597000 USD · 2016-01-01 – 2016-03-31 Source
Revenue: 68125000 USD · 2016-04-01 – 2016-06-30 Source
Revenue: 46016000 USD · 2016-07-01 – 2016-09-30 Source

Net income

-31.6 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Net income: -231156000 USD · 2015-01-01 – 2015-12-31 Source
Net income: -171285000 USD · 2015-01-01 – 2015-09-30 Source
Net income: -53787000 USD · 2016-01-01 – 2016-03-31 Source
Net income: 109848000 USD · 2016-04-01 – 2016-06-30 Source
Net income: -27827000 USD · 2016-07-01 – 2016-09-30 Source

Operating cash flow

-160 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Operating cash flow: -159245000 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -120658000 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -65095000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -97747000 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -65095000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -121436000 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -97747000 USD · 2016-01-01 – 2016-06-30 Source

Capital expenditure

1.51 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Capital expenditure: 1344000 USD · 2010-01-01 – 2010-12-31 Source
Capital expenditure: 980000 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 423000 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 977000 USD · 2011-01-01 – 2011-06-30 Source
Capital expenditure: 423000 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 1147000 USD · 2011-01-01 – 2011-09-30 Source
Capital expenditure: 977000 USD · 2011-01-01 – 2011-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-02-13.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2015-12-31
Operating income: 11 of 11 periods available· newest 2015-12-31
Net income: 11 of 11 periods available· newest 2015-12-31
Operating cash flow: 11 of 11 periods available· newest 2015-12-31
Capital expenditure: 6 of 11 periods available· newest 2010-12-31
Total assets: 8 of 11 periods available· newest 2015-12-31
Total liabilities: 2 of 11 periods available· newest 2015-12-31
Current assets: 8 of 11 periods available· newest 2015-12-31
Current liabilities: 8 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2015-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2015-12-31
Shares outstanding: 6 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+12.7%

Prior period

USD 105.41 million

2014-01-01 – 2014-12-31
Current period

USD 118.8 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

118804000 − 105412000 = 13392000 USD

105412000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
118804000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ARIAD PHARMACEUTICALS INC · 2015-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Year-over-year change in Revenue: 13392000 USD Concept: fundies:Revenue Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 118804000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#864120 Filing: 000119312516485544 Input fundies:Revenue: 105412000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#160625 Filing: 000119312516485544
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 68.55 million

Prior period

−USD 162.6 million

2014-01-01 – 2014-12-31
Current period

−USD 231.16 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-231156000 − -162602000 = -68554000 USD

-162602000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-231156000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ARIAD PHARMACEUTICALS INC · 2015-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Year-over-year change in Net income: -68554000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -231156000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#868563 Filing: 000119312516485544 Input fundies:NetIncome: -162602000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#164481 Filing: 000119312516485544
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 101.45 million

Prior period

−USD 57.79 million

2014-01-01 – 2014-12-31
Current period

−USD 159.25 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-159245000 − -57794000 = -101451000 USD

-57794000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-159245000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ARIAD PHARMACEUTICALS INC · 2015-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Year-over-year change in Operating cash flow: -101451000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -159245000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#547058 Filing: 000119312516485544 Input fundies:OperatingCashFlow: -57794000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#152947 Filing: 000119312516485544
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

Revenue USD 118.8 million 100% of revenue
Cost of revenue USD 2.11 million 1.8% of revenue
Operating expenses USD 336.08 million 283% of revenue
Other operating costs Derived −USD 2.11 million −1.8% of revenue
Operating income −USD 217.28 million −183% of revenue
Tax, interest and other Derived USD 13.88 million 12% of revenue
Net income −USD 231.16 million −195% of revenue

Cash

Operating cash flow −USD 159.25 million −134% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Operating loss: operating costs were 1,115% of revenue.
2009 Operating loss: operating costs were 968% of revenue.
2010 48%11%41%
2011 Operating loss: operating costs were 404% of revenue.
2012 Operating loss: operating costs were 36,849% of revenue.
2013 Operating loss: operating costs were 700% of revenue.
2014 Operating loss: operating costs were 252% of revenue.
2015 Operating loss: operating costs were 283% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	7082000	78933000 Derived	-71851000	-799000 Derived	-71052000	-54902000 Derived	Source 2008-01-01 – 2008-12-31: 7082000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -71851000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -71052000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -48251000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 6651000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	8302000	80335000 Derived	-72033000	7975000 Derived	-80008000	-54102000 Derived	Source 2009-01-01 – 2009-12-31: 8302000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -72033000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -80008000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -51904000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 2198000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	178980000	74080000 Derived	104900000	19652000 Derived	85248000	5074000 Derived	Source 2010-01-01 – 2010-12-31: 178980000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 104900000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 85248000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 6418000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 1344000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	25300000	102123000 Derived	-76823000	46780000 Derived	-123603000	Unavailable	Source 2011-01-01 – 2011-12-31: 25300000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -76823000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -123603000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -53262000 USD Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	558000	205618000 Derived	-205060000	15812000 Derived	-220872000	Unavailable	Source 2012-01-01 – 2012-12-31: 558000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -205060000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -220872000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -153681000 USD Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	45561000	319127000 Derived	-273566000	592000 Derived	-274158000	Unavailable	Source 2013-01-01 – 2013-12-31: 45561000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -273566000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -274158000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -221882000 USD Inspect Operating Cash Flow Open source
2014 2014-01-01 – 2014-12-31	105412000	265607000 Derived	-160195000	2407000 Derived	-162602000	Unavailable	Source 2014-01-01 – 2014-12-31: 105412000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -160195000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -162602000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -57794000 USD Inspect Operating Cash Flow Open source
2015 2015-01-01 – 2015-12-31	118804000	336080000 Derived	-217276000	13880000 Derived	-231156000	Unavailable	Source 2015-01-01 – 2015-12-31: 118804000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -217276000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -231156000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -159245000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 118.8M 2015

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	7082000	Revenue: 7082000 Open source
20092009-12-31	Revenue	8302000	Revenue: 8302000 Open source
20102010-12-31	Revenue	178980000	Revenue: 178980000 Open source
20112011-12-31	Revenue	25300000	Revenue: 25300000 Open source
20122012-12-31	Revenue	558000	Revenue: 558000 Open source
20132013-12-31	Revenue	45561000	Revenue: 45561000 Open source
20142014-12-31	Revenue	105412000	Revenue: 105412000 Open source
20152015-12-31	Revenue	118804000	Revenue: 118804000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

12.7% 2015

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: 7082000 Open source
20092009-12-31	Year over year	17.2%	Revenue: 8302000 Open source Revenue: 7082000 Open source
20102010-12-31	Year over year	2,055.9%	Revenue: 178980000 Open source Revenue: 8302000 Open source
20112011-12-31	Year over year	-85.9%	Revenue: 25300000 Open source Revenue: 178980000 Open source
20122012-12-31	Year over year	-97.8%	Revenue: 558000 Open source Revenue: 25300000 Open source
20132013-12-31	Year over year	8,065.1%	Revenue: 45561000 Open source Revenue: 558000 Open source
20142014-12-31	Year over year	131.4%	Revenue: 105412000 Open source Revenue: 45561000 Open source
20152015-12-31	Year over year	12.7%	Revenue: 118804000 Open source Revenue: 105412000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -182.9% 2015

Net margin -194.6% 2015

Free cash flow margin 2.8% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	-1,014.6%	Operating Income: -71851000 Open source Revenue: 7082000 Open source
20092009-12-31	Operating margin	-867.7%	Operating Income: -72033000 Open source Revenue: 8302000 Open source
20102010-12-31	Operating margin	58.6%	Operating Income: 104900000 Open source Revenue: 178980000 Open source
20112011-12-31	Operating margin	-303.6%	Operating Income: -76823000 Open source Revenue: 25300000 Open source
20122012-12-31	Operating margin	-36,749.1%	Operating Income: -205060000 Open source Revenue: 558000 Open source
20132013-12-31	Operating margin	-600.4%	Operating Income: -273566000 Open source Revenue: 45561000 Open source
20142014-12-31	Operating margin	-152%	Operating Income: -160195000 Open source Revenue: 105412000 Open source
20152015-12-31	Operating margin	-182.9%	Operating Income: -217276000 Open source Revenue: 118804000 Open source
20082008-12-31	Net margin	-1,003.3%	Net Income: -71052000 Open source Revenue: 7082000 Open source
20092009-12-31	Net margin	-963.7%	Net Income: -80008000 Open source Revenue: 8302000 Open source
20102010-12-31	Net margin	47.6%	Net Income: 85248000 Open source Revenue: 178980000 Open source
20112011-12-31	Net margin	-488.5%	Net Income: -123603000 Open source Revenue: 25300000 Open source
20122012-12-31	Net margin	-39,582.8%	Net Income: -220872000 Open source Revenue: 558000 Open source
20132013-12-31	Net margin	-601.7%	Net Income: -274158000 Open source Revenue: 45561000 Open source
20142014-12-31	Net margin	-154.3%	Net Income: -162602000 Open source Revenue: 105412000 Open source
20152015-12-31	Net margin	-194.6%	Net Income: -231156000 Open source Revenue: 118804000 Open source
20082008-12-31	Free cash flow margin	-775.2%	Revenue: 7082000 Open source Operating Cash Flow: -48251000 Open source Capital Expenditure: 6651000 Open source
20092009-12-31	Free cash flow margin	-651.7%	Revenue: 8302000 Open source Operating Cash Flow: -51904000 Open source Capital Expenditure: 2198000 Open source
20102010-12-31	Free cash flow margin	2.8%	Revenue: 178980000 Open source Operating Cash Flow: 6418000 Open source Capital Expenditure: 1344000 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 25300000 Open source Operating Cash Flow: -53262000 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 558000 Open source Operating Cash Flow: -153681000 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 45561000 Open source Operating Cash Flow: -221882000 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 105412000 Open source Operating Cash Flow: -57794000 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 118804000 Open source Operating Cash Flow: -159245000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -159.2M 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	-48251000	Operating Cash Flow: -48251000 Open source
20092009-12-31	Operating cash flow	-51904000	Operating Cash Flow: -51904000 Open source
20102010-12-31	Operating cash flow	6418000	Operating Cash Flow: 6418000 Open source
20112011-12-31	Operating cash flow	-53262000	Operating Cash Flow: -53262000 Open source
20122012-12-31	Operating cash flow	-153681000	Operating Cash Flow: -153681000 Open source
20132013-12-31	Operating cash flow	-221882000	Operating Cash Flow: -221882000 Open source
20142014-12-31	Operating cash flow	-57794000	Operating Cash Flow: -57794000 Open source
20152015-12-31	Operating cash flow	-159245000	Operating Cash Flow: -159245000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 5.1M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	-54902000	Operating Cash Flow: -48251000 Open source Capital Expenditure: 6651000 Open source
20092009-12-31	Free cash flow	-54102000	Operating Cash Flow: -51904000 Open source Capital Expenditure: 2198000 Open source
20102010-12-31	Free cash flow	5074000	Operating Cash Flow: 6418000 Open source Capital Expenditure: 1344000 Open source
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -53262000 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -153681000 Open source
20132013-12-31	Free cash flow	Unavailable	Operating Cash Flow: -221882000 Open source
20142014-12-31	Free cash flow	Unavailable	Operating Cash Flow: -57794000 Open source
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: -159245000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

118.9% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2008-12-31	Liabilities / assets	Not reported	Total Assets: 68188000 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 65010000 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 120030000 Open source
2011-12-31	Liabilities / assets	Not reported	Total Assets: 320712000 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 180193000 Open source
2013-12-31	Liabilities / assets	Not reported	Total Assets: 370894000 Open source
20142014-12-31	Liabilities / assets	86.6%	Total Liabilities: 522315000 Open source Total Assets: 603116000 Open source
20152015-12-31	Liabilities / assets	118.9%	Total Liabilities: 649833000 Open source Total Assets: 546692000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.08× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	1.39×	Current Assets: 48004000 Open source Current Liabilities: 34529000 Open source
20092009-12-31	Current assets / current liabilities	1.22×	Current Assets: 45896000 Open source Current Liabilities: 37684000 Open source
20102010-12-31	Current assets / current liabilities	6.41×	Current Assets: 105172000 Open source Current Liabilities: 16397000 Open source
20112011-12-31	Current assets / current liabilities	12.12×	Current Assets: 307567000 Open source Current Liabilities: 25372000 Open source
20122012-12-31	Current assets / current liabilities	3.45×	Current Assets: 168350000 Open source Current Liabilities: 48866000 Open source
20132013-12-31	Current assets / current liabilities	3.39×	Current Assets: 244946000 Open source Current Liabilities: 72177000 Open source
20142014-12-31	Current assets / current liabilities	4.29×	Current Assets: 385642000 Open source Current Liabilities: 89998000 Open source
20152015-12-31	Current assets / current liabilities	2.08×	Current Assets: 275197000 Open source Current Liabilities: 132284000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	−USD 61.93 million Exact value Exact value: -61928000 USD 2006-01-01 – 2006-12-31: -61928000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARIAD PHARMACEUTICALS INC · 2006-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Net Income: -61928000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -61928000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-09-002131.txt#10064 The citation records this snapshot. The page link may show a newer release later.	−USD 56.04 million Exact value Exact value: -56038000 USD 2006-01-01 – 2006-12-31: -56038000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARIAD PHARMACEUTICALS INC · 2006-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Operating Cash Flow: -56038000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -56038000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-09-002131.txt#10372 The citation records this snapshot. The page link may show a newer release later.	USD 1.07 million Exact value Exact value: 1067000 USD 2006-01-01 – 2006-12-31: 1067000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARIAD PHARMACEUTICALS INC · 2006-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Capital Expenditure: 1067000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1067000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-09-002131.txt#10449 The citation records this snapshot. The page link may show a newer release later.	−USD 57.11 million Calculation and evidence -56038000 − 1067000 USD Exact free cash flow: -57105000 USD 2006-01-01 – 2006-12-31: -56038000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 1067000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARIAD PHARMACEUTICALS INC · 2006-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Free cash flow: -57105000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -56038000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-09-002131.txt#10372 Input fundies:CapitalExpenditure: 1067000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-09-002131.txt#10449 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 58.52 million Exact value Exact value: -58522000 USD 2007-01-01 – 2007-12-31: -58522000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARIAD PHARMACEUTICALS INC · 2007-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Net Income: -58522000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -58522000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-10-001604.txt#8099 The citation records this snapshot. The page link may show a newer release later.	USD 33.99 million Exact value Exact value: 33988000 USD 2007-01-01 – 2007-12-31: 33988000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARIAD PHARMACEUTICALS INC · 2007-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Operating Cash Flow: 33988000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 33988000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-10-001604.txt#8387 The citation records this snapshot. The page link may show a newer release later.	USD 1.35 million Exact value Exact value: 1346000 USD 2007-01-01 – 2007-12-31: 1346000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARIAD PHARMACEUTICALS INC · 2007-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Capital Expenditure: 1346000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1346000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-10-001604.txt#8467 The citation records this snapshot. The page link may show a newer release later.	USD 32.64 million Calculation and evidence 33988000 − 1346000 USD Exact free cash flow: 32642000 USD 2007-01-01 – 2007-12-31: 33988000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 1346000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARIAD PHARMACEUTICALS INC · 2007-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Free cash flow: 32642000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 33988000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-10-001604.txt#8387 Input fundies:CapitalExpenditure: 1346000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-10-001604.txt#8467 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 71.05 million Exact value Exact value: -71052000 USD 2008-01-01 – 2008-12-31: -71052000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARIAD PHARMACEUTICALS INC · 2008-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Net Income: -71052000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -71052000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-11-001591.txt#8111 The citation records this snapshot. The page link may show a newer release later.	−USD 48.25 million Exact value Exact value: -48251000 USD 2008-01-01 – 2008-12-31: -48251000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARIAD PHARMACEUTICALS INC · 2008-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Operating Cash Flow: -48251000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48251000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-11-001591.txt#8401 The citation records this snapshot. The page link may show a newer release later.	USD 6.65 million Exact value Exact value: 6651000 USD 2008-01-01 – 2008-12-31: 6651000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARIAD PHARMACEUTICALS INC · 2008-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Capital Expenditure: 6651000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6651000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-11-001591.txt#8481 The citation records this snapshot. The page link may show a newer release later.	−USD 54.9 million Calculation and evidence -48251000 − 6651000 USD Exact free cash flow: -54902000 USD 2008-01-01 – 2008-12-31: -48251000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 6651000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARIAD PHARMACEUTICALS INC · 2008-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Free cash flow: -54902000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -48251000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-11-001591.txt#8401 Input fundies:CapitalExpenditure: 6651000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-11-001591.txt#8481 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 80.01 million Exact value Exact value: -80008000 USD 2009-01-01 – 2009-12-31: -80008000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARIAD PHARMACEUTICALS INC · 2009-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Net Income: -80008000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -80008000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000115752312001634/aria-20111231.xml#60765 Filing: 000115752312001634 The citation records this snapshot. The page link may show a newer release later.	−USD 51.9 million Exact value Exact value: -51904000 USD 2009-01-01 – 2009-12-31: -51904000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARIAD PHARMACEUTICALS INC · 2009-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Operating Cash Flow: -51904000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51904000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000115752312001634/aria-20111231.xml#57703 Filing: 000115752312001634 The citation records this snapshot. The page link may show a newer release later.	USD 2.2 million Exact value Exact value: 2198000 USD 2009-01-01 – 2009-12-31: 2198000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARIAD PHARMACEUTICALS INC · 2009-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Capital Expenditure: 2198000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2198000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-11-001591.txt#8481 The citation records this snapshot. The page link may show a newer release later.	−USD 54.1 million Calculation and evidence -51904000 − 2198000 USD Exact free cash flow: -54102000 USD 2009-01-01 – 2009-12-31: -51904000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 2198000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARIAD PHARMACEUTICALS INC · 2009-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Free cash flow: -54102000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51904000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000115752312001634/aria-20111231.xml#57703 Filing: 000115752312001634 Input fundies:CapitalExpenditure: 2198000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-11-001591.txt#8481 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	USD 85.25 million Exact value Exact value: 85248000 USD 2010-01-01 – 2010-12-31: 85248000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARIAD PHARMACEUTICALS INC · 2010-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Net Income: 85248000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 85248000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312513087814/aria-20121231.xml#89458 Filing: 000119312513087814 The citation records this snapshot. The page link may show a newer release later.	USD 6.42 million Exact value Exact value: 6418000 USD 2010-01-01 – 2010-12-31: 6418000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARIAD PHARMACEUTICALS INC · 2010-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Operating Cash Flow: 6418000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6418000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312513087814/aria-20121231.xml#81676 Filing: 000119312513087814 The citation records this snapshot. The page link may show a newer release later.	USD 1.34 million Exact value Exact value: 1344000 USD 2010-01-01 – 2010-12-31: 1344000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARIAD PHARMACEUTICALS INC · 2010-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Capital Expenditure: 1344000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1344000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-11-001591.txt#8481 The citation records this snapshot. The page link may show a newer release later.	USD 5.07 million Calculation and evidence 6418000 − 1344000 USD Exact free cash flow: 5074000 USD 2010-01-01 – 2010-12-31: 6418000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 1344000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARIAD PHARMACEUTICALS INC · 2010-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Free cash flow: 5074000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6418000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312513087814/aria-20121231.xml#81676 Filing: 000119312513087814 Input fundies:CapitalExpenditure: 1344000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/0001157523-11-001591.txt#8481 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 123.6 million Exact value Exact value: -123603000 USD 2011-01-01 – 2011-12-31: -123603000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARIAD PHARMACEUTICALS INC · 2011-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Net Income: -123603000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -123603000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312514080539/aria-20131231.xml#95953 Filing: 000119312514080539 The citation records this snapshot. The page link may show a newer release later.	−USD 53.26 million Exact value Exact value: -53262000 USD 2011-01-01 – 2011-12-31: -53262000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARIAD PHARMACEUTICALS INC · 2011-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Operating Cash Flow: -53262000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -53262000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312514080539/aria-20131231.xml#90083 Filing: 000119312514080539 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 220.87 million Exact value Exact value: -220872000 USD 2012-01-01 – 2012-12-31: -220872000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARIAD PHARMACEUTICALS INC · 2012-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Net Income: -220872000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -220872000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312515073392/aria-20141231.xml#893963 Filing: 000119312515073392 The citation records this snapshot. The page link may show a newer release later.	−USD 153.68 million Exact value Exact value: -153681000 USD 2012-01-01 – 2012-12-31: -153681000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARIAD PHARMACEUTICALS INC · 2012-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Operating Cash Flow: -153681000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -153681000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312515073392/aria-20141231.xml#885637 Filing: 000119312515073392 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 274.16 million Exact value Exact value: -274158000 USD 2013-01-01 – 2013-12-31: -274158000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARIAD PHARMACEUTICALS INC · 2013-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Net Income: -274158000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -274158000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#128852 Filing: 000119312516485544 The citation records this snapshot. The page link may show a newer release later.	−USD 221.88 million Exact value Exact value: -221882000 USD 2013-01-01 – 2013-12-31: -221882000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARIAD PHARMACEUTICALS INC · 2013-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Operating Cash Flow: -221882000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -221882000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#119553 Filing: 000119312516485544 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 162.6 million Exact value Exact value: -162602000 USD 2014-01-01 – 2014-12-31: -162602000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARIAD PHARMACEUTICALS INC · 2014-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Net Income: -162602000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -162602000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#164481 Filing: 000119312516485544 The citation records this snapshot. The page link may show a newer release later.	−USD 57.79 million Exact value Exact value: -57794000 USD 2014-01-01 – 2014-12-31: -57794000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARIAD PHARMACEUTICALS INC · 2014-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Operating Cash Flow: -57794000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -57794000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#152947 Filing: 000119312516485544 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 231.16 million Exact value Exact value: -231156000 USD 2015-01-01 – 2015-12-31: -231156000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARIAD PHARMACEUTICALS INC · 2015-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Net Income: -231156000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -231156000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#868563 Filing: 000119312516485544 The citation records this snapshot. The page link may show a newer release later.	−USD 159.25 million Exact value Exact value: -159245000 USD 2015-01-01 – 2015-12-31: -159245000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARIAD PHARMACEUTICALS INC · 2015-12-31 ARIAD PHARMACEUTICALS INC (edgar:884731) Operating Cash Flow: -159245000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:44:13Z Snapshot: 4089770bb89bd088f69c3ae9eb7a8783909c0c8842950362e1a1c6b3a3ccb1a1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/884731/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -159245000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/884731/000119312516485544/aria-20151231.xml#547058 Filing: 000119312516485544 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

160 filings · 1,844 latest values · 1,844 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000884731, 884731, ARIA, edgar:884731

Also known as ARIAD PHARMACEUTICALS INC

ARIAD PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2015 2015-01-01 – 2015-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation